Capsule fecal transplant to prevent C. difficile coming back
Part of Infections clinical trials.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign the consent form
- You have C. difficile infection confirmed by stool testing, either a first episode with higher relapse risk or a first recurrence
- You have had no more than 2 C. difficile episodes in the past 3 months
- You are starting C. difficile antibiotics (vancomycin or fidaxomicin) now (or have started within the last 10 days)
- You are able and willing to take the FMT capsules
- You do not have severe, life-threatening complications from C. difficile (like shock or a perforated or dangerously enlarged colon)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares three treatments for a severe diarrhea infection called C. diff: a fecal transplant (putting healthy donor stool into your gut), a newer antibiotic called fidaxomicin, and an older antibiotic called vancomycin. The goal is to see which works best and prevents the infection from coming back.
This trial tests whether giving a stool transplant (also called FMT) can treat a new, early C. difficile infection in people who have improved while on antibiotics. It may help some people prevent the infection from coming back or worsening.
This study tests a freeze-dried fecal microbiota transplant (FMT) to see if it helps with diarrhea-predominant irritable bowel syndrome (IBS-D) or prevents repeat C. diff infections. FMT introduces healthy bacteria into your gut to restore balance.
This study is looking at people who were treated for C. diff (a serious gut infection) at Umeå University Hospital to see how they are doing years later. It compares people who got a fecal transplant (a treatment that restores healthy gut bacteria) with those who only took antibiotics.
This study tests whether specific lifestyle changes during treatment for C. difficile infection (a serious gut bacteria infection) can help prevent it from coming back. You'll receive standard antibiotic treatment and follow a controlled diet while researchers track your recovery.
This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.